RS55530B1 - So fotosenzitivnog agensa za upotrebu u fotohemijskoj internalizaciji - Google Patents

So fotosenzitivnog agensa za upotrebu u fotohemijskoj internalizaciji

Info

Publication number
RS55530B1
RS55530B1 RS20161158A RSP20161158A RS55530B1 RS 55530 B1 RS55530 B1 RS 55530B1 RS 20161158 A RS20161158 A RS 20161158A RS P20161158 A RSP20161158 A RS P20161158A RS 55530 B1 RS55530 B1 RS 55530B1
Authority
RS
Serbia
Prior art keywords
salt
photosensitizing agent
photochemical internalization
internalization
photochemical
Prior art date
Application number
RS20161158A
Other languages
English (en)
Inventor
Jo Klaveness
Anders Hogset
Original Assignee
Pci Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pci Biotech As filed Critical Pci Biotech As
Publication of RS55530B1 publication Critical patent/RS55530B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RS20161158A 2009-08-14 2010-08-16 So fotosenzitivnog agensa za upotrebu u fotohemijskoj internalizaciji RS55530B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0914287.8A GB0914287D0 (en) 2009-08-14 2009-08-14 Compositions
EP10747249.0A EP2464384B1 (en) 2009-08-14 2010-08-16 Salt of a photosensitizing agent for use in photochemical internalization
PCT/GB2010/001547 WO2011018635A2 (en) 2009-08-14 2010-08-16 Photosensitizing compositions

Publications (1)

Publication Number Publication Date
RS55530B1 true RS55530B1 (sr) 2017-05-31

Family

ID=41171444

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20161158A RS55530B1 (sr) 2009-08-14 2010-08-16 So fotosenzitivnog agensa za upotrebu u fotohemijskoj internalizaciji

Country Status (23)

Country Link
US (1) US9026203B2 (sr)
EP (1) EP2464384B1 (sr)
JP (1) JP5946407B2 (sr)
KR (1) KR101795362B1 (sr)
CN (1) CN102648004B (sr)
AU (1) AU2010283565B2 (sr)
BR (1) BR112012003283B1 (sr)
CA (1) CA2771021C (sr)
DK (1) DK2464384T3 (sr)
ES (1) ES2610143T3 (sr)
GB (1) GB0914287D0 (sr)
HR (1) HRP20161712T1 (sr)
LT (1) LT2464384T (sr)
ME (1) ME02616B (sr)
MX (1) MX337481B (sr)
NZ (1) NZ598380A (sr)
PL (1) PL2464384T3 (sr)
PT (1) PT2464384T (sr)
RS (1) RS55530B1 (sr)
RU (1) RU2574019C2 (sr)
SG (1) SG178420A1 (sr)
SI (1) SI2464384T1 (sr)
WO (1) WO2011018635A2 (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
US9693957B2 (en) 2011-07-08 2017-07-04 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
GB201208548D0 (en) 2012-05-15 2012-06-27 Pci Biotech As Compound and method
WO2014179760A1 (en) 2013-05-03 2014-11-06 The Regents Of The University Of California Cyclic di-nucleotide induction of type i interferon
EP3038619B1 (en) * 2013-08-28 2023-10-04 PCI Biotech AS Compound and method for vaccination and immunisation
US10206871B2 (en) 2014-10-14 2019-02-19 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
KR101736149B1 (ko) * 2015-09-30 2017-05-17 (주)나노팜 여드름 피부개선을 위한 광민감성 물질을 함유한 건식다중캡슐형 조성물 및 그의 제조방법
CN109310702A (zh) 2016-05-20 2019-02-05 芝加哥大学 用于化学疗法、靶向疗法、光动力疗法、免疫疗法和它们的任何组合的纳米颗粒
RU2019109682A (ru) 2016-10-14 2020-11-16 ПиСиАй БИОТЕК АС Лечение холангиокарциномы с применением tpcs-2-индуцированной фотохимической интернализации гемцитабина
CN111194232B (zh) 2017-08-02 2023-01-31 芝加哥大学 纳米级金属有机层和金属有机纳米片
CN107722075A (zh) * 2017-10-09 2018-02-23 大连理工大学 一类二氢卟吩葡萄糖苷类化合物及其制备方法与应用
GB201718631D0 (en) 2017-11-10 2017-12-27 Pci Biotech As Method
RU2720799C1 (ru) * 2019-07-03 2020-05-13 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ определения фракционного состава сульфированного фталоцианина алюминия
RU2757936C1 (ru) * 2021-03-12 2021-10-25 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития хронической истинной экземы на основе молекулярно-генетических данных

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
JPH0753861B2 (ja) * 1985-04-15 1995-06-07 味の素株式会社 紫外線吸収剤
US5284647A (en) 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
IT1254045B (it) * 1991-12-31 1995-09-06 Lifegroup Spa Derivati idrosolubili della biotina e relative composizioni terapeutiche
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
FR2700543B1 (fr) * 1993-01-15 1995-03-17 Synthelabo Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.
DE4305523A1 (de) 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
DE69817529T2 (de) 1998-02-19 2004-06-24 Microflow Engineering S.A. Vorrichtung und Gerät zur intrakavitären Wirkstofffreigabe während videounterstützter Chirurgie oder anderer endoskopischer Verfahren
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
US6398748B1 (en) 1999-03-16 2002-06-04 Robert B. Wilson Splint bandage and method
US6570013B2 (en) * 2000-02-16 2003-05-27 Pfizer Inc Salts of zopolrestat
KR20030074633A (ko) 2000-11-29 2003-09-19 피씨아이 바이오테크 에이에스 사이토졸 내로의 바이러스 매개된 분자 전달을 위한광화학적 내부이행
WO2002044396A1 (en) 2000-11-29 2002-06-06 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
CN1823038B (zh) 2003-05-14 2010-05-12 索科普哈应用研究产品商业化公司-健康与人类科学Sec 双亲性三磺酸化四氮杂卟啉在医药中的光动力学应用
GB0415263D0 (en) 2004-07-07 2004-08-11 Norwegian Radium Hospital Res Method
GB2420784A (en) 2004-11-25 2006-06-07 Pci Biotech As Phototherapeutic amphiphilic phthalocyanine-based compounds where 1 peripheral ring system is more hydrophilic & has more hydrophilic groups than the other 3
GB0514743D0 (en) * 2005-07-19 2005-08-24 Astrazeneca Ab Salt
ES2400091T3 (es) 2005-08-11 2013-04-05 Massachusetts Institute Of Technology Dispositivo de suministro de fármacos intravesical y método
GB0605743D0 (en) * 2006-03-22 2006-05-03 Oxagen Ltd Salts with CRTH2 antagonist activity
JP2008095050A (ja) 2006-10-16 2008-04-24 Hidetoshi Tsuchida アルブミン−金属ポルフィリン複合体および光増感剤
GB0811955D0 (en) 2008-06-30 2008-07-30 Pci Biotech As Method
GB0914286D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions

Also Published As

Publication number Publication date
JP2013501769A (ja) 2013-01-17
EP2464384B1 (en) 2016-10-12
LT2464384T (lt) 2017-04-10
NZ598380A (en) 2014-04-30
SI2464384T1 (sl) 2017-04-26
DK2464384T3 (en) 2017-01-23
ME02616B (me) 2017-06-20
HRP20161712T1 (hr) 2017-04-21
JP5946407B2 (ja) 2016-07-06
KR101795362B1 (ko) 2017-11-08
BR112012003283A8 (pt) 2016-05-17
BR112012003283A2 (pt) 2016-03-01
PT2464384T (pt) 2017-01-12
CN102648004A (zh) 2012-08-22
AU2010283565B2 (en) 2015-12-10
CN102648004B (zh) 2015-07-22
WO2011018635A3 (en) 2011-07-07
BR112012003283B1 (pt) 2020-06-16
MX337481B (es) 2016-03-08
WO2011018635A2 (en) 2011-02-17
RU2574019C2 (ru) 2016-01-27
CA2771021C (en) 2018-02-20
MX2012001953A (es) 2012-03-29
KR20120094900A (ko) 2012-08-27
AU2010283565A1 (en) 2012-03-15
US20120226217A1 (en) 2012-09-06
RU2012109559A (ru) 2013-09-20
GB0914287D0 (en) 2009-09-30
EP2464384A2 (en) 2012-06-20
PL2464384T3 (pl) 2017-06-30
SG178420A1 (en) 2012-04-27
ES2610143T3 (es) 2017-04-26
US9026203B2 (en) 2015-05-05
CA2771021A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
LT2464384T (lt) Fotosensitizuojančio agento druska, skirta naudoti fotocheminei internalizacijai
GB0908957D0 (en) Therapeutic agents
HK1162498A1 (en) Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd copd 5--2-
HK1162258A1 (en) Agent for enhancing taste of common salt
EP2510949A4 (en) THERAPEUTICS FOR FIBROMYALGIA
EP2444467A4 (en) AQUEOUS ADHESIVE AGENT COMPOSITION
EP2416776A4 (en) USE OF TETRAHYDROBIOPTERIN AS A MARKER AND THERAPEUTIC AGENT IN FABRY'S DISEASE
IL209462A0 (en) Opiorphin for use as a psychotimulant agent
GB0900484D0 (en) Therapeutic agent
IL216308A0 (en) Use of delta-tocopheryl-carbohydrate as a depigmenting agent
ZA201202464B (en) Inorganic salt complexes of vildagliptin
EP2486929A4 (en) ANTI-TUMOR THERAPEUTIC AGENT
GB0901465D0 (en) Compounds for use in therapy
IL216224A0 (en) Desfesoterodine in the form of a tartaric acid salt
PL2509448T3 (pl) Nowy czynnik zastępujący NaCl
GB0910493D0 (en) Therapeutic agents
PL389125A1 (pl) Środek warroabójczy w formie kształtki
GB0919819D0 (en) Therapeutic agents
GB0915586D0 (en) Therapeutic agents
GB0919825D0 (en) Therapeutic agents
GB0919829D0 (en) Therapeutic agents
GB0911965D0 (en) Therapeutic agents
GB0919820D0 (en) Therapeutic agents
GB0903949D0 (en) Therapeutic agents
GB0907971D0 (en) Therapeutic agents